I-Ashwagandha

-Delile

• Kungenzeka kusebenze ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

I-Ashwagandha isihlahlana esincane esihlala siluhlaza. Ikhula eNdiya, eMiddle East, nasezingxenyeni ezithile ze-Afrika. Impande nejikijolo kusetshenziselwa ukwenza umuthi.

I-Ashwagandha ijwayele ukusetshenziselwa ukucindezeleka. Iphinde isetshenziswe njenge "adaptogen" yezinye izimo eziningi, kepha abukho ubufakazi obuhle besayensi obusekela lokhu okunye ukusetshenziswa.

Ungaphambanisi i-ashwagandha nePhysalis alkekengi. Zombili zaziwa njenge-cherry yasebusika. Futhi, ungadidanisi i-ashwagandha ne-ginseng yaseMelika, iPanax ginseng, noma i-eleuthero.

Isifo seCoronavirus 2019 (COVID-19): Abukho ubufakazi obuhle bokusekela ukusebenzisa i-ashwagandha ye-COVID-19. Landela izindlela zokuphila ezinempilo nezindlela zokuvikela ezifakazelwe esikhundleni salokho.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze ASHWAGANDHA zimi kanje:

Kungenzeka kusebenze ...

• Ukucindezeleka. Olunye ucwaningo lubonisa ukuthi ukuthatha i-ashwagandha root extract ethile (i-KSM66, i-Ixoreal Biomed) i-300 mg kabili ngosuku ngemuva kokudla noma okunye ukukhishwa okuthile (i-Shoden, i-Arjuna Natural Ltd.) i-240 mg nsuku zonke izinsuku ezingama-60 ibonakala ithuthukisa izimpawu zokuxineka.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukuguga. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha izimpande ze-ashwagandha kusiza ukuthuthukisa inhlalakahle, ikhwalithi yokulala, nokuqapha kwengqondo ngamanani amancane ukuya kokulinganayo kubantu abaneminyaka engama-65-80.
• Imiphumela emibi ye-Metabolic ebangelwa yimithi elwa nezengqondo. Ama-antipsychotic asetshenziselwa ukwelapha i-schizophrenia kepha angadala amazinga amafutha kanye noshukela osegazini ukuthi ande. Ukuthatha i-ashwagandha ethize ekhishwe (i-Cap Strelaxin, M / s Pharmanza Herbal Pvt. Ltd.) 400 mg kathathu nsuku zonke inyanga eyodwa kunganciphisa amazinga amafutha neshukela egazini kubantu abasebenzisa le mithi.
• Ukukhathazeka. Olunye ucwaningo lokuqala lukhombisa ukuthi ukuthatha i-ashwagandha kunganciphisa ezinye izimpawu zesimo sokukhathazeka.
• Ukusebenza kwezemidlalo. Olunye ucwaningo lukhombisa ukuthi ukuthatha i-ashwagandha kusiza ekutheni ungakanani umoya-mpilo umzimba ongawusebenzisa ngesikhathi sokuvivinya umzimba. Kepha akwaziwa ukuthi lokhu kuyasiza ukuthuthukisa ukusebenza.
• Ukuphazamiseka kwe-bipolar. Ukuthatha i-ashwagandha ethize ekhishwe (i-Sensoril, Natreon, Inc.) yamaviki angu-8 kungahle kuthuthukise ukusebenza kobuchopho kubantu abalashelwa ukuphazamiseka kwengqondo okuguquguqukayo.
• Ukukhathala kwabantu abaphathwa ngemithi yomdlavuza. Ucwaningo lwakuqala luphakamisa ukuthatha i-ashwagandha ethize ekhishwe i-2000 mg (Himalaya Drug Co, New Delhi, India) ngesikhathi sokwelashwa ngamakhemikhali kunganciphisa imizwa yokukhathala.
• Isifo sikashukela. Kunobunye ubufakazi bokuthi i-ashwagandha inganciphisa amazinga kashukela egazini kubantu abanesifo sikashukela.
• Uhlobo lokukhathazeka okuphikelelayo oluphawulwe ukukhathazeka ngokweqile nokungezwani (ukukhathazeka okujwayelekile ukukhathazeka noma i-GAD). Olunye ucwaningo lokuqala lomtholampilo lubonisa ukuthi ukuthatha i-ashwagandha kunganciphisa ezinye izimpawu zokukhathazeka.
• I-cholesterol ephezulu. Kunobunye ubufakazi bokuthi i-ashwagandha inganciphisa amazinga e-cholesterol ezigulini ezine-cholesterol ephezulu.
• I-thyroid engasebenzi (i-hypothyroidism). Abantu abane-thyroid engasebenzi kahle banezinga eliphakeme legazi le-hormone ebizwa nge-thyroid stimulating hormone (TSH). Abantu abane-thyroid engasebenzi bangaba namazinga aphansi e-hormone ye-thyroid. Ukuthatha i-ashwagandha kubonakala kwehlisa i-TSH futhi kwandise amazinga e-thyroid yegciwane kubantu abanefomu elincane le-thyroid engasebenzi.
• Ukuqwasha. Olunye ucwaningo lubonisa ukuthi ukuthatha i-ashwagandha kungasiza abantu ukuthi balale kangcono.
• Izimo kumuntu wesilisa ezimvimbela ukuthi akhulelise owesifazane kungakapheli unyaka wokuzama ukukhulelwa (ukungazali kwabesilisa)Olunye ucwaningo lwakuqala lukhombisa ukuthi i-ashwagandha ingahle ithuthukise ikhwalithi yesidoda nokubalwa kwesidoda emadodeni angenanzalo. Kepha akucaci ukuthi i-ashwagandha ingakwazi ngempela ukuthuthukisa ukuzala.
• Uhlobo lokukhathazeka olumakwe yimicabango ephindaphindwayo nokuziphatha okuphindaphindwayo (ukukhathazeka ngokweqile noma i-OCD). Ucwaningo lokuqala lukhombisa ukuthi i-ashwagandha impande ekhishwayo inganciphisa izimpawu ze-OCD lapho ithathwa ngemithi enqunyiwe yamaviki ayisithupha.
• Izinkinga zocansi ezivimbela ukwaneliseka ngesikhathi socansi. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-ashwagandha kukhishwa nsuku zonke amasonto ayi-8 kanye nokwelulekwa kukhulisa intshisekelo kwezocansi nokwaneliseka kwezocansi kwabesifazane abadala abanokukhubazeka ngokocansi kangcono kunokululekwa kuphela.
• Ukunakwa kokushoda-i-hyperactivity disorder (ADHD).
• Ukulimala kobuchopho okuthinta ukunyakaza kwemisipha (i-cerebellar ataxia).
• I-osteoarthritis.
• Isifo se-Parkinson.
• Isifo samathambo (RA).
• Ukuguqula ukusebenza komzimba.
• I-Fibromyalgia.
• Ukunciphisa ukuhlanza.
• Izinkinga zesibindi.
• Ukuvuvukala (ukuvuvukala).
• Izimila.
• Isifo sofuba.
• Izilonda, lapho zisetshenziswa esikhunjeni.
• Ezinye izimo.

Kudingeka ubufakazi obengeziwe ukukala ukusebenza kwe-ashwagandha kulokhu kusetshenziswa.

I-Ashwagandha iqukethe amakhemikhali angasiza ukuzola ubuchopho, anciphise ukuvuvukala (ukuvuvukala), anciphise umfutho wegazi, futhi aguqule amasosha omzimba.

Lapho ithathwa ngomlomo: I-Ashwagandha iyi OKUNGENZEKA UKUPHEPHA lapho ithathwa izinyanga ezifika kwezintathu. Ukuphepha kwesikhathi eside kwe-ashwagandha akwaziwa. Imithamo emikhulu ye-ashwagandha ingadala ukucasuka kwesisu, isifo sohudo nokuhlanza. Ngokuvamile, izinkinga zesibindi zingavela.

Lapho isetshenziswa esikhunjeni: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi i-ashwagandha iphephile yini noma yini imiphumela emibi engaba yiyo.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Ikona Cishe UNGAPHEPHILE ukusebenzisa i-ashwagandha lapho ukhulelwe. Kunobunye ubufakazi bokuthi i-ashwagandha ingadala ukukhushulwa kwezisu. Alukho ulwazi olwanele olunokwethenjelwa lokwazi ukuthi i-ashwagandha iphephile yini ukusebenzisa lapho uncelisa. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

"Izifo zokuzivikela ngokuzenzakalela" njenge-multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), isifo samathambo (RA), noma ezinye izimo: I-Ashwagandha ingadala ukuthi amasosha omzimba asebenze kakhudlwana, futhi lokhu kungakhuphula izimpawu zezifo zokuzivikela komzimba. Uma unenye yalezi zimo, kungcono ukugwema ukusebenzisa i-ashwagandha.

Ukuhlinzwa: I-Ashwagandha inganciphisa uhlelo oluphakathi lwezinzwa. Abahlinzeki bezokunakekelwa kwezempilo bakhathazeka ngokuthi i-anesthesia neminye imishanguzo ngesikhathi nangemva kokuhlinzwa ingakhuphula lo mphumela. Yeka ukuthatha i-ashwagandha okungenani amasonto ama-2 ngaphambi kokuhlinzwa okuhleliwe.

Izinkinga ze-thyroid: I-Ashwagandha ingakhuphula amazinga ama-hormone e-thyroid. I-Ashwagandha kufanele isetshenziswe ngokuqapha noma ngokugwenywa uma unesimo se-thyroid noma uthatha imishanguzo yehomoni yegilo.

Maphakathi

Qaphela ngale nhlanganisela.

Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)

I-Ashwagandha inganciphisa amazinga kashukela egazini. Imithi yesifo sikashukela nayo isetshenziselwa ukwehlisa ushukela egazini. Ukuthatha i-ashwagandha kanye nemithi yesifo sikashukela kungadala ukuthi ushukela wegazi lakho wehle kakhulu. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imishanguzo esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-metformin (i-Glucophage), i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbotide Orinase), nabanye.

Imithi yokwelapha umfutho wegazi ophakeme (Imithi efuthayo)

I-Ashwagandha inganciphisa umfutho wegazi. Ukuthatha i-ashwagandha ngemithi esetshenziselwa ukwelapha umfutho wegazi ophakeme kungahle kudale ukuthi amazinga egazi anciphe aye phansi.

Eminye imishanguzo yomfutho wegazi ophakeme ihlanganisa i-captopril (Capoten), i-enalapril (i-Vasotec), i-losartan (i-Cozaar), i-valsartan (i-Diovan), i-diltiazem (i-Cardizem), i-amlodipine (i-Norvasc), i-hydrochlorothiazide (i-HydroDIURIL), i-furosemide (i-Lasix), neminye eminingi .

Imithi eyehlisa amasosha omzimba (ama-Immunosuppressants)

I-Ashwagandha kubonakala sengathi yenza amasosha omzimba asebenze kakhudlwana. Ukuthatha i-ashwagandha kanye nemithi eyehlisa amasosha omzimba kunganciphisa ukusebenza kwale mithi.

Eminye imishanguzo eyehlisa amasosha omzimba ifaka i-azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), nabanye.

Imithi yokwelapha (i-Benzodiazepines)

I-Ashwagandha ingadala ukozela nokozela. Izidakamizwa ezibangela ukulala nozela zibizwa ngokuthi yimishanguzo. Ukuthatha i-ashwagandha kanye nemithi yokwelapha kungadala ukulala kakhulu.

Eminye yale mithi yokudambisa umzimba ihlanganisa i-clonazepam (iKlonopin), i-diazepam (i-Valium), i-lorazepam (i-Ativan), i-alprazolam (i-Xanax), i-flurazepam (i-Dalmane), i-midazolam (i-Versed), neminye.

Imithi yokudambisa (i-CNS depressants)

I-Ashwagandha ingadala ukozela nokozela. Imithi ebanga ubuthongo ibizwa ngokuthi yimithi yokuthambisa. Ukuthatha i-ashwagandha kanye nemithi yokwelapha kungadala ukulala kakhulu.

Eminye imishanguzo yokuthambisa ibandakanya i-clonazepam (iKlonopin), i-lorazepam (Ativan), i-phenobarbital (iDonnatal), i-zolpidem (i-Ambien), neminye.

Indlala yegilo

Umzimba ngokwemvelo ukhiqiza ama-hormone e-thyroid. I-Ashwagandha ingakhuphula ukuthi umzimba ukhiqiza i-hormone engakanani yegilo. Ukuthatha i-ashwagandha ngamaphilisi e-thyroid kungadala i-hormone yegilo emzimbeni, futhi kukhulise imiphumela kanye nemiphumela emibi yehomoni yegilo.

Amakhambi nezengezo ezinganciphisa umfutho wegazi

I-Ashwagandha inganciphisa umfutho wegazi. Ukuhlanganisa i-ashwagandha namanye amakhambi kanye nezithasiselo ezibuye zinciphise umfutho wegazi kungadala ukuthi umfutho wegazi uye phansi. Amanye amakhambi nezithasiselo zalolu hlobo kufaka phakathi i-andrographis, ama-casein peptides, uzipho lwekati, i-coenzyme Q-10, uwoyela wezinhlanzi, i-L-arginine, i-lyceum, i-nettle netingayo, i-theanine, nezinye.

Amakhambi kanye nezithasiselo ezinezakhiwo zokuthambisa

I-Ashwagandha ingenza njengokuthambisa. Lokho wukuthi, kungadala ukulala. Ukuyisebenzisa kanye namanye amakhambi nezithako ezisebenza njengezidakamizwa kungadala ukulala okuningi. Ezinye zazo zihlanganisa i-5-HTP, i-calamus, i-poppy yaseCalifornia, i-catnip, i-hops, i-dogwood yaseJamaican, i-kava, iSt John's wort, i-skullcap, i-valerian, i-yerba mansa, nezinye.

Akukho ukuxhumana okwaziwayo nokudla.

NGOMLOMO:

• Ukuze uthole ukucindezeleka: Impande ye-Ashwagandha ikhipha u-300 mg kabili ngosuku ngemuva kokudla (i-KSM66, i-Ixoreal Biomed) noma i-240 mg nsuku zonke (iShoden, i-Arjuna Natural Ltd.) izinsuku ezingama-60.

I-Ajagandha, Amangura, Amukkirag, Asan, Asana, Asgand, Asgandh, Asgandha, Ashagandha, Ashvagandha, Ashwaganda, Ashwanga, Asoda, Asundha, Asvagandha, Aswagandha, Avarada, Ayurvedic Ginseng, Cerise d'Hiver, Asheroda Ginteng , Ginseng Indien, Hayahvaya, Indian Ginseng, Kanaje Hindi, Kuthmithi, Orovale, Peyette, Physalis somnifera, Samm Al Ferakh, Samm Al Rerakh, Sogade-Beru, Strychnos, Turangi-Ghanda, Vajigandha, Winter Cherry, Withania, Withania somnifera.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UDeshpande A, Irani N, uBalkrishnan R, uBenny IR. Ucwaningo olulawulwa ngokungahleliwe, oluyimpumputhe, oluyi-placebo lokuhlola imiphumela ye-ashwagandha (Withania somnifera) ekhishwa kukhwalithi yokulala kubantu abadala abaphilile. Ukulala Med. 2020; 72: 28-36. Buka okungaqondakali.
2. I-Fuladi S, i-Emami SA, i-Mohammadpour AH, i-Karimani A, i-Manteghi AA, i-Sahebkar A. Ukuhlolwa kwe-Andania somnifera impande kukhipha ukusebenza kahle kweziguli ezinenkinga yokukhathazeka okujwayelekile: Isivivinyo esilawulwa ngokungahleliwe esilawulwa yi-placebo. ICurr Clin Pharmacol. 2020. Buka okungaqondakali.
3. UBjörnsson HK, uBjörnsson ES, uAvula B, et al. Ukulimala kwesibindi okubangelwa i-Ashwagandha: Uchungechunge lwamacala avela e-Iceland kanye ne-US Drug-Induced Liver Injury Network. Isibindi Int. 2020; 40: 825-829. Buka okungaqondakali.
4. UDurg S, uBavage S, uShivaram SB. U-Withania somnifera (i-ginseng yaseNdiya) ku-diabetes mellitus: Ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kobufakazi besayensi kusuka ocwaningweni lokuhlola kuya kusicelo somtholampilo. I-Phytother Res. 2020; 34: 1041-1059. Buka okungaqondakali.
5. UKelgane SB, uSalve J, uSampara P, uDebnath K. Ukusebenza nokubekezelela ukukhishwa kwezimpande ze-ashwagandha kubantu asebekhulile ukuze kuthuthukiswe inhlalakahle nokulala okujwayelekile: Ucwaningo olulawulwa yi-placebo. UCureus. 2020; 12: e7083. Buka okungaqondakali.
6. UPérez-Gómez J, Villafaina S, Adsuar JC, Merellano-Navarro E, Collado-Mateo D. Imiphumela ye-ashwagandha (Withania somnifera) ku-VO2max: Ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. Izakhamzimba. 2020; 12: 1119. Buka okungaqondakali.
7. USalve J, uPate S, uDebnath K, uLangade D.Imiphumela ye-Adaptogenic kanye ne-anxiolytic yemiphumela yezimpande ze-ashwagandha kubantu abadala abanempilo: Ucwaningo lomtholampilo olulawulwa kabili, olungahleliwe nolulawulwa yi-placebo. UCureus. 2019; 11: e6466. Buka okungaqondakali.
8. I-Lopresti AL, Smith SJ, Malvi H, Kodgule R. Uphenyo mayelana nezenzo zokuqeda ukucindezeleka kanye nezemithi ze-ashwagandha (Withania somnifera) ekhishwe: Ucwaningo olulawulwa ngokungahleliwe, oluyimpumputhe, olulawulwa kabili. Imithi (iBaltimore). 2019; 98: e17186. Buka okungaqondakali.
9. USharma AK, uBasu I, uS Singh S. Ukusebenza nokuphepha kwe-Ashwagandha impande ekhishwe kwiziguli ze-subclinical hypothyroid: isilingo esilawulwa kabili, esilawulwa ngokungahleliwe. UJ Altern Complement Med. 2018 uMar; 24: 243-248. Buka okungaqondakali.
10. UKumar G, uSrivastava A, uSharma SK, uRao TD, uGupta YK. Ukuhlolwa kokusebenza nokuphepha kokwelashwa kwe-ayurvedic (ashwagandha powder kanye no-sidh makardhwaj) ezigulini ze-rheumatoid arthritis: isifundo somqondo wokushayela. I-Indian J Med Res 2015 Jan; 141: 100-6. Buka okungaqondakali.
11. UDongre S, Langade D, Bhattacharyya S. Ukusebenza nokuphepha kwe-ashwagandha (withania somnifera) kukhishwe impande ekwenzeni ngcono ukusebenza kwezocansi kwabesifazane: isifundo somshayeli. I-Biomed Res Int 2015; 2015: 284154.
12. UJahanbakhsh SP, uManteghi AA, u-Emami SA, uMahyari S, et al. Ukuhlolwa kokusebenza kahle kwe-withania somnifera (ashwagandha) impande ekhishwe ezigulini ezinesifo sokucindezela okucindezelayo: isilingo esilawulwa ngokungahleliwe esilawulwa yi-placebo. Qedela iTher Med 2016 Aug; 27: 25-9.
13. UChoudhary D, uBhattacharyya S, uJoshi K. Ukuphathwa kwesisindo somzimba kubantu abadala abangaphansi kwengcindezi engapheli ngokwelashwa nge-ashwagandha impande ekhishwe: isilingo esilawulwa kabili, esingahleliwe, esilawulwa yi-placebo. UJ Evid Osekwe Ngokuhambisana Okuphelele I-Med Med. 2017 Jan; 22: 96-106 Buka okungaqondakali.
14. USud Khyati S, Thaker B. Isifundo esilawulwa ngokungahleliwe esilawulwa nge-placebo kabili esilawulwa nge-ashwagandha esihlahleni sokukhathazeka esijwayelekile. I-Int Ayurvedic Med J 2013; 1: 1-7.
15. UChengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Ucwaningo olwenziwe ngokulawulwa kwe-placebo olulawulwa ngokungahleliwe lokukhishwa kwe-andania somnifera yokungasebenzi kahle kwengqondo ku-bipolar disorder. J Clin Psychiatry. 2013; 74: 1076-83. Buka okungaqondakali.
16. I-Chandrasekhar K, Kapoor J, i-Anishetty S. Isifundo esilawulwayo, esilawulwa ngokungahleliwe sokuphepha nokusebenza ngempumelelo kokukhishwa okuphelele kwe-ashwagandha okugxile ekunciphiseni ukucindezeleka nokukhathazeka kubantu abadala. I-Indian J Psychol Med. 2012; 34: 255-62. Buka okungaqondakali.
17. IBiswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Umphumela ka-Andania somnifera (Ashwagandha) ekwakhiweni kokukhathala okubangelwa ngamakhemikhali kanye nekhwalithi yempilo ezigulini zomdlavuza webele. I-Cancer Ther ehlanganisiwe. 2013; 12: 312-22. Buka okungaqondakali.
18. Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Ukuhlolwa Kwemitholampilo Komsebenzi We-Spermatogenic we-Root Extract yase-Ashwagandha (Withania somnifera) e-Oligospermic Male: A Pilot Study. I-Evid Based Complement Alternat Med. 2013; 2013: 571420. Buka okungaqondakali.
19. I-Agnihotri AP, iSontakke SD, iThawani VR, iSooji A, iGoswami VS. Imiphumela ye-Andania somnifera ezigulini ze-schizophrenia: isifundo esenziwa ngokungahleliwe, esiyimpumputhe, esilawulwa nge-placebo. I-Indian J Pharmacol. 2013; 45: 417-8. Buka okungaqondakali.
20. U-Anbalagan K noSadique J. Withania somnifera (ashwagandha), umuthi wamakhambi ovuselelayo olawula ukuhlanganiswa kwe-alpha-2 macroglobulin ngesikhathi sokuvuvukala. I-Int. J. Crude Drug Res. 1985; 23: 177-183.
21. UVenkataraghavan S, uSeshadri C, uSundaresan TP, no-al. Umphumela wokuqhathanisa wobisi oqiniswe nge-Aswagandha, Aswagandha nePunarnava ezinganeni - isifundo esiyimpumputhe. UJ Res Ayur Sid 1980; 1: 370-385.
22. UGhosal S, uLal J, uSrivastava R, no-al. Imiphumela ye-Immunomodulatory kanye ne-CNS yama-sitoindosides 9 no-10, ama-glycowithanolides amabili avela ku-Andania somnifera. Ucwaningo lwePhytotherapy 1989; 3: 201-206.
23. Upadhaya L futhi et al. Indima yesidakamizwa sendabuko iGeriforte emazingeni egazi ama-biogenic amine nokubaluleka kwawo ekwelapheni i-neurosis yokukhathazeka. I-Acta Nerv Super 1990; 32: 1-5.
24. U-Ahumada F, u-Aspee F, uWikman G, no-al. Withania somnifera akhiphe. Umphumela wayo ekucindezelekeni kwegazi ezinjeni ezingafakwanga izinzwa. Ucwaningo lwe-Phytotherapy 1991; 5: 111-114.
25. UKuppurajan K, uRajagopalan SS, uSitoraman R, no-al. Umphumela we-Ashwagandha (Withania somnifera Dunal) kunqubo yokuguga kumavolontiya angabantu. Ijenali yocwaningo e-Ayurveda naseSiddha 1980; 1: 247-258.
26. UDhuley, J. N. Umphumela we-ashwagandha ku-lipid peroxidation ezilwaneni ezibangelwa ukucindezeleka. J Ethnopharmacol. 1998; 60: 173-178. Buka okungaqondakali.
27. UDhuley, J. N. Ukusebenza kahle kwe-Ashwagandha ngokumelene ne-aspergillosis yokuhlola kumagundane. I-Immunopharmacol.Immunotoxicol. 1998; 20: 191-198. Buka okungaqondakali.
28. USharada, A. C., Solomon, F. E., Devi, P. U., Udupa, N., noSrinivasan, K. K. Antitumor kanye nemiphumela ye-radiosensitizing ye-withaferin A kumagundane u-Ehrlich ascites carcinoma in vivo. I-Acta Oncol. 1996; 35: 95-100. Buka okungaqondakali.
29. UDevi, P. U., Sharada, A. C., noSolomon, F. E. Antitumor kanye nemithelela ye-radiosensitizing ka-Andania somnifera (Ashwagandha) esihlahleni segundane elingatshintshwa, iSarcoma-180. I-Indian J Exp Biol. 1993; 31: 607-611. Buka okungaqondakali.
30. UPraveenkumar, V., Kuttan, R., noKuttan, G. Isenzo sokuzivikela samaRasayanas ngokulwa nobuthi be-cyclosphamide. UTumori 8-31-1994; 80: 306-308. Buka okungaqondakali.
31. UDevi, P. U., Sharada, A. C., noSolomon, F. E. Ku-vivo ukukhula kwemiphumela yokuvimbela kanye ne-radiosensitizing ye-withaferin A yegundane i-Ehrlich ascites carcinoma. Umdlavuza Lett. 8-16-1995; 95 (1-2): 189-193. Buka okungaqondakali.
32. U-Anbalagan, K. noSadique, J. Ithonya lomuthi waseNdiya (i-Ashwagandha) kuma-reactants esigaba esibuhlungu ngokuvuvukala. I-Indian J Exp Biol. 1981; 19: 245-249. Buka okungaqondakali.
33. Malhotra, C. L., Mehta, V. L., Prasad, K., noDas, P. K. Izifundo ku-Andania ashwagandha, Kaul. IV. Umphumela wama-alkaloid aphelele emisipheni ebushelelezi. I-Indian J Physiol Pharmacol. 1965; 9: 9-15. Buka okungaqondakali.
34. Malhotra, C. L., Mehta, V. L., Das, P. K., noDhalla, N. S. Izifundo ku-Andania-ashwagandha, Kaul. V. Umphumela wama-alkaloid aphelele (ashwagandholine) ohlelweni oluphakathi lwezinzwa. I-Indian J Physiol Pharmacol. Ngo-1965; 9: 127-136. Buka okungaqondakali.
35. Begum, V. H. and Sadique, J. Umphumela wesikhathi eside womuthi wamakhambi u-Andania somnifera ku-adjuvant eyenziwe ngamathambo kumagundane. I-Indian J Exp Biol. 1988; 26: 877-882. Buka okungaqondakali.
36. UVaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, SP, Kaul, SC, Sekar, K., noWadhwa, R. Imisebenzi eyahlukile. kwama-antiolides amabili ahlobene eduze, i-Withaferin A ne-Andanone: i-bioinformatics kanye nobufakazi bokuhlola. PLoS.One. 2012; 7: e44419. Buka okungaqondakali.
37. Sehgal, V. N., Verma, P., noBhattacharya, S. N. Ukuqhuma kwesidakamizwa okungaguquki okubangelwa yi-ashwagandha (Withania somnifera): umuthi osetshenziswa kakhulu we-Ayurvedic. Isikhumba. 2012; 10: 48-49. Buka okungaqondakali.
38. UMalviya, N., Jain, S., Gupta, V. B., noVyas, S. Ucwaningo lwamuva ngamakhambi e-aphrodisiac okuphathwa kokungasebenzi kahle kowesilisa - ukubuyekeza. Acta Pol. Umkhakha. 2011; 68: 3-8. Buka okungaqondakali.
39. UVen Murthy, M.R, Ranjekar, P.K, Ramassamy, C., noDeshpande, M.Isisekelo sesayensi sokusetshenziswa kwezitshalo zokwelapha zase-Indian ayurvedic ekwelapheni ukuphazamiseka kwe-neurodegenerative: ashwagandha. I-Cent.Nerv.Syst.Agents Med.Chem. 9-1-2010; 10: 238-246. Buka okungaqondakali.
40. UBhat, J., Damle, A., Vaishnav, P. P., Albers, R., Joshi, M., noBanerjee, G. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. I-Phytother.I-2010; 24: 129-135. Buka okungaqondakali.
41. UMikolai, J., Erlandsen, A., Murison, A., Brown, K. A., Gregory, W. L., Raman-Caplan, P., noZwickey, H. L. In vivo imiphumela ye-Ashwagandha (Withania somnifera) ekhishwe ekusebenzeni kwama-lymphocyte. J. Altern.Complement Med. U-2009; 15: 423-430. Buka okungaqondakali.
42. Lu, L., Liu, Y., Zhu, W., Shi, J., Liu, Y., Ling, W., noKosten, T. R. Imithi yendabuko ekwelapheni ukulutha kwezidakamizwa. U-Am J Ukuphuza Kabi Utshwala 2009; 35: 1-11. Buka okungaqondakali.
43. USingh, R.H, uNarsimhamurthy, K., noSingh, uG. Neuronutrient umthelela wokwelashwa kwe-Ayurvedic Rasayana ekugugeni kobuchopho. I-Biogerontology. 2008; 9: 369-374. Buka okungaqondakali.
44. UTohda, C. [Ukunqoba izifo eziningana zokungenwa yimithambo ngokwemithi yendabuko: ukuthuthukiswa kwemithi yokwelapha nokuqaqa izindlela ze-pathophysiological]. Yakugaku Zasshi 2008; 128: 1159-1167. Buka okungaqondakali.
45. UDeocaris, C. C., Widodo, N., Wadhwa, R., noKaul, S. C. Ukuhlanganiswa kwe-ayurveda kanye nezicubu zomzimba ezisebenza ngamasiko: ukukhuthazwa okuvela ezinhlelweni zebhayoloji. Kuhumushe. 2008; 6: 14. Buka okungaqondakali.
46. UKulkarni, S. K. noDhir, A. Withania somnifera: i-ginseng yaseNdiya. Inkungu. Neuropsychopharmacol. Biol. I-Psychiatry 7-1-2008; 32: 1093-1105. Buka okungaqondakali.
47. IChoudhary, MI, Nawaz, SA, ul-Haq, Z., Lodhi, MA, Ghayur, MN, Jalil, S., Riaz, N., Yousuf, S., Malik, A., Gilani, AH, kanye ne- ur- URahman, A. Withanolides, isigaba esisha semvelo se-cholinesterase inhibitors esinezinto eziphikisana ne-calcium. I-Biochem.I-Biophys.I-Comm Commun. 8-19-2005; 334: 276-287. Buka okungaqondakali.
48. UKhattak, S., Saeed, Ur Rehman, Shah, H. U., Khan, T., no-Ahmad, M. In vitro enzyme inhibition activities of crude ethanolic extracts etholakala ezitshalweni zokwelapha zasePakistan. Nat.Prod.Res 2005; 19: 567-571. Buka okungaqondakali.
49. UKaur, K., Rani, G., Widodo, N., Nagpal, A., Taira, K., Kaul, SC, noWadhwa, R. Ukuhlolwa kwemisebenzi yokulwa nokwanda nokulwa ne-oxidative yokukhishwa kweqabunga i-vivo ne-in vitro bakhulise i-Ashwagandha. Ukudla Chem. I-Toxicol. 2004; 42: 2015-2020. Buka okungaqondakali.
50. UDevi, P. U., Sharada, A. C., Solomon, F. E., noKamath, M. S. In vivo effect inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol. 1992; 30: 169-172. Buka okungaqondakali.
51. UGupta, S. K., Dua, A., noVohra, B. P. Withania somnifera (Ashwagandha) unciphisa ukuzivikela kwe-antioxidant entanjeni endala yomgogodla futhi kuvimbela ithusi elenziwe nge-lipid peroxidation kanye nokuguqulwa kwamaprotheni oxidative. Ukuhlangana Kwezidakamizwa. 2003; 19: 211-222. Buka okungaqondakali.
52. UBhattacharya, S. K. noMuruganandam, A. V. Umsebenzi we-Adaptogenic ka-Andania somnifera: isifundo sokuhlola kusetshenziswa imodeli yegundane yengcindezi engapheli. I-Pharmacol Biochem. Behav 2003; 75: 547-555. Buka okungaqondakali.
53. UDavis, L. noKuttan, G. Umphumela we-Andania somnifera ku-DMBA eyenga i-carcinogenesis. J Ethnopharmacol. 2001; 75 (2-3): 165-168. Buka okungaqondakali.
54. UBhattacharya, S. K., Bhattacharya, A., Sairam, K., noGhosal, S. Umsebenzi we-Anxiolytic-antidepressant ka-Andania somnifera glycowithanolides: isifundo sokuhlola. I-Phytomedicine 2000; 7: 463-469. Buka okungaqondakali.
55. IPanda S, Kar A. Izinguquko ekugxileni kwehomoni ye-thyroid ngemuva kokuphathwa kwe-ashwagandha impande ekhishwe kumagundane amadala amaduna. UJ Pharm Pharmacol 1998; 50: 1065-68. Buka okungaqondakali.
56. IPanda S, Kar A. Withania somnifera neBauhinia purpurea ekulawulweni kokujikeleza ukugxila kwamahomoni wegilo kumagundane abesifazane. UJ Ethnopharmacol 1999; 67: 233-39. Buka okungaqondakali.
57. I-Agarwal R, i-Diwanay S, i-Patki P, i-Patwardhan B. Ucwaningo lomsebenzi we-immunomodulatory we-Andania somnifera (Ashwagandha) ekhishwe ekuvukeleni komzimba wokuhlola. UJ Ethnopharmacol 1999; 67: 27-35. Buka okungaqondakali.
58. U-Ahumada F, Aspee F, Wikman G, Hancke J. Withania somnifera exract. Imiphumela yayo ekucindezelekeni kwegazi ezinjeni ezingafakwanga izinzwa. I-Phytother Res 1991; 5: 111-14.
59. UKulkarni RR, uPatki PS, uJog VP, et al. Ukwelashwa kwe-osteoarthritis ngokwakhiwa kwe-herbomineral: isifundo esiyimpumputhe, esilawulwa yi-placebo, esiphambanweni. J Ethnopharmacol 1991; 33: 91-5. Buka okungaqondakali.
60. U-Ahmad MK, Mahdi AA, uShukla KK, et al. I-Withania somnifera ithuthukisa ikhwalithi yesidoda ngokulawula amazinga e-hormone okuzala kanye nengcindezi ye-oxidative ku-seminal plasma yabesilisa abangazali. Okuzalayo 2010; 94: 989-96. Buka okungaqondakali.
61. U-Andallu B, uRadhika B. Hypoglycemic, umthelela we-diuretic kanye ne-hypocholesterolemic we-cherry yasebusika (Withania somnifera, Dunal) impande. I-Indian J Exp Biol 2000; 38: 607-9. Buka okungaqondakali.
62. I-Sriranjini SJ, i-Pal PK, i-Devidas KV, i-Ganpathy S. Ukwenza ngcono ibhalansi kuma-ataxias e-degenerative degenerative aqhubeka ngemuva kokwelashwa kwe-Ayurvedic: umbiko wokuqala. INeurol India 2009; 57: 166-71. Buka okungaqondakali.
63. UKatz M, uLevine AA, uKol-Degani H, uKav-Venaki L. Ukulungiswa kwamakhambi okuhlanganiswa (CHP) ekwelapheni izingane ezine-ADHD: isilingo esilawulwa ngokungahleliwe. UJ Atten Disord 2010; 14: 281-91. Buka okungaqondakali.
64. UCooley K, uSzczurko O, uPerri D, et al. Ukunakekelwa kwe-Naturopathic kokukhathazeka: isilingo esilawulwa ngokungahleliwe ISRC TN78958974. Ama-PLoS One 2009; 4: e6628. Buka okungaqondakali.
65. I-Dasgupta A, Tso G, Wells A. Umphumela we-ginseng yase-Asia, i-ginseng yaseSiberia, nomuthi wama-ayurvedic wase-India u-Ashwagandha kusilinganiso se-serum digoxin nguDigoxin III, i-digoxin immunoassay entsha. UJ Clin Lab Anal 2008; 22: 295-301. Buka okungaqondakali.
66. UDasgupta A, uPeterson A, Wells A, Umlingisi uJK. Umphumela womuthi wase-Ayurvedic wase-India u-Ashwagandha esilinganisweni se-serum digoxin nezidakamizwa eziyi-11 ezijwayele ukubhekwa zisebenzisa ama-immunoassays: ukutadisha ukubopha kwamaprotheni nokuxhumana ne-Digibind. I-Arch Pathol Lab Med 2007; 131: 1298-303. Buka okungaqondakali.
67. UMishra LC, Singh BB, Dagenais S. Isisekelo sesayensi sokusetshenziswa kokwelashwa kwe-Andania somnifera (ashwagandha): ukubuyekeza. I-Altern Med Rev 2000; 5: 334-46. Buka okungaqondakali.
68. UNagashayana N, uSankarankutty P, uNampoothiri MRV, et al. Ukuhlangana kwe-l-DOPA ngokululama kulandela imishanguzo ye-Ayurveda eSifo sikaParkinson. UJ Neurol Sci 2000; 176: 124-7. Buka okungaqondakali.
69. I-Bhattacharya SK, i-Satyan KS, i-Ghosal S. Umsebenzi we-Antioxidant we-glycowithanolides ovela ku-Andania somnifera. I-Indian J Exp Biol 1997; 35: 236-9. Buka okungaqondakali.
70. UDavis L, uKuttan G. Umphumela ocindezelayo wobuthi obenziwe yi-cyclophosphamide ngu-Andania somnifera okhishwe kumagundane. UJ Ethnopharmacol 1998; 62: 209-14. Buka okungaqondakali.
71. I-Archana R, Namasivayam A. Umphumela we-Antistressor we-Andania somnifera. UJ Ethnopharmacol 1999; 64: 91-3. Buka okungaqondakali.
72. UDavis L, Kuttan G. Umphumela ka-Andania somnifera ku-cyclophosphamide-indased urotoxicity. ICancer Lett 2000; 148: 9-17. Buka okungaqondakali.
73. Upton R, ed. I-Ashwagandha Root (Withania somnifera): Ukuhlaziya, ukulawula ikhwalithi, kanye ne-therapuetic monograph. ISanta Cruz, CA: I-American Herbal Pharmacopoeia 2000: 1-25.
74. UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ama-eds. Ibhuku le-American Herbal Products Association's Botanical Safety Handbook. IBoca Raton, FL: CRC Press, LLC 1997.

Kugcine ukubuyekezwa - 12/16/2020